A phase 2 study of frontline pembrolizumab in follicular lymphoma is a research paper published in eJHaem (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: T32HL007093
National Institutes of Health
Grant: 2T32HL007093-36
HEMATOLOGY TRAINING
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5K24CA184039-04
Molecularly Targeted Therapy for Lymphoma
Fields of Study
Keywords